Colgate-Palmolive (NYSE:CL) Shares Acquired by Catalina Capital Group LLC

Catalina Capital Group LLC increased its position in Colgate-Palmolive (NYSE:CL) by 20.8% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,593 shares of the company’s stock after purchasing an additional 446 shares during the period. Catalina Capital Group LLC’s holdings in Colgate-Palmolive were worth $269,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of CL. Price T Rowe Associates Inc. MD grew its stake in Colgate-Palmolive by 27.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock worth $3,698,096,000 after purchasing an additional 8,933,912 shares in the last quarter. Swedbank AB acquired a new position in Colgate-Palmolive in the first quarter worth about $286,370,000. Acadian Asset Management LLC lifted its holdings in Colgate-Palmolive by 108.4% in the second quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company’s stock worth $551,367,000 after acquiring an additional 2,955,442 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in Colgate-Palmolive by 40.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company’s stock worth $870,400,000 after acquiring an additional 2,593,313 shares during the last quarter. Finally, Ossiam lifted its holdings in Colgate-Palmolive by 368.4% in the first quarter. Ossiam now owns 1,563,768 shares of the company’s stock worth $140,817,000 after acquiring an additional 1,229,891 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Colgate-Palmolive

In other news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.37% of the stock is currently owned by company insiders.

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $90.21 on Thursday. The company’s fifty day moving average is $101.49 and its two-hundred day moving average is $98.39. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 12-month low of $74.67 and a 12-month high of $109.30. The company has a market cap of $73.70 billion, a P/E ratio of 25.85, a price-to-earnings-growth ratio of 3.33 and a beta of 0.42.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.22%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. Jefferies Financial Group cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their target price for the stock from $103.00 to $95.00 in a report on Wednesday, July 24th. Hsbc Global Res cut Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a report on Friday, July 26th. Piper Sandler initiated coverage on Colgate-Palmolive in a report on Tuesday, September 24th. They set an “overweight” rating and a $121.00 price target on the stock. HSBC reaffirmed a “hold” rating on shares of Colgate-Palmolive in a report on Friday, July 26th. Finally, Deutsche Bank Aktiengesellschaft cut Colgate-Palmolive from a “buy” rating to a “hold” rating and lifted their price target for the company from $107.00 to $109.00 in a report on Monday, September 9th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $105.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.